InvestorsHub Logo
Followers 16
Posts 1771
Boards Moderated 0
Alias Born 09/05/2017

Re: Amatuer17 post# 357936

Thursday, 04/21/2022 4:55:03 PM

Thursday, April 21, 2022 4:55:03 PM

Post# of 462030
This is why Missling is so frustrating....he doesn't share anything substantive on his thinking. My guess is that he did what some on this board advocated. Namely, a focus on Rett to get it across the finish line, gain credibility, revenue, etc. and also on AD since he was on Phase 3 or 2b or whatever with its giant potential as a value creator. Everything else would have to wait - i.e. no movement on PDD or PD. I don't have any issue with this thought process. My issue is with Missling's distrust of his shareholder base by not explaining any of this to us so were left with educated guesses, game theory and outright speculation. At the end of the day MIssling is exactly like most small biotech CEOs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News